GlassScriptPhysician profile
Elann Barnes
NPI 1114452372
$564.46
in general payments reported to CMS, 2019-2025
13 companies · $22.80 in 2025
The $22.80 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $402 · 2022: $48.02 · 2023: $14.77 · 2024: $77.24 · 2025: $22.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $114.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $127.48 | 2021-2023 | Bexsero |
| Pfizer INC. | $102.55 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $58.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $45.11 | 2021 | |
| Sanofi Pasteur INC. | $43.95 | 2022-2024 | |
| Kaleo, INC. | $43.66 | 2021 | |
| Genzyme Corporation | $30.97 | 2024 | |
| Eyevance Pharmaceuticals LLC | $23.20 | 2021 | |
| Biocryst US Sales Co., LLC | $22.38 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.72 | 2021 | |
| Cranial Technologies, INC | $18.15 | 2024 | Doc Band |
| Merck Sharp & Dohme LLC | $14.78 | 2024 | Gardasil 9, Vaqta, Gardasil |
| Teva Pharmaceuticals USA, INC. | $14.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elann Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.